Literature DB >> 18291371

The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases.

Carlos A Zarate1, Husseini K Manji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18291371      PMCID： PMC2441819          DOI： 10.1016/j.expneurol.2008.01.011

Source DB:  PubMed          Journal:  Exp Neurol        ISSN： 0014-4886            Impact factor:   5.330


× No keyword cloud information.
  28 in total

1.  Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers.

Authors:  Elke Wezenberg; Robert Jan Verkes; Ge S F Ruigt; Wouter Hulstijn; Bernard G C Sabbe
Journal:  Neuropsychopharmacology       Date:  2006-11-22       Impact factor: 7.853

Review 2.  AMPA receptors in the therapeutic management of depression.

Authors:  D Bleakman; A Alt; J M Witkin
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-04       Impact factor: 4.388

3.  Behavioral and biological effects of chronic S18986, a positive AMPA receptor modulator, during aging.

Authors:  Erik B Bloss; Richard G Hunter; Elizabeth M Waters; Carmen Munoz; Katie Bernard; Bruce S McEwen
Journal:  Exp Neurol       Date:  2007-10-24       Impact factor: 5.330

Review 4.  Alzheimer's disease and mild cognitive impairment.

Authors:  Brendan J Kelley; Ronald C Petersen
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

5.  AMPA potentiator treatment of cognitive deficits in Alzheimer disease.

Authors:  A S Chappell; C Gonzales; J Williams; M M Witte; R C Mohs; R Sperling
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

6.  A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.

Authors:  Donald C Goff; J Steven Lamberti; Andrew C Leon; Michael F Green; Alexander L Miller; Jayendra Patel; Theo Manschreck; Oliver Freudenreich; Steven A Johnson
Journal:  Neuropsychopharmacology       Date:  2007-05-09       Impact factor: 7.853

7.  AMPA receptor potentiation can prevent ethanol-induced intoxication.

Authors:  Nicholas Jones; Marcus J Messenger; Michael J O'Neill; Anna Oldershaw; Gary Gilmour; Rosa M A Simmons; Smriti Iyengar; Vincenzo Libri; Mark Tricklebank; Steve C R Williams
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

Review 8.  Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder.

Authors:  Robert J Schloesser; Jian Huang; Peter S Klein; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2007-10-03       Impact factor: 7.853

9.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

Review 10.  AMPA receptor potentiators: application for depression and Parkinson's disease.

Authors:  Michael J O'Neill; Jeffrey M Witkin
Journal:  Curr Drug Targets       Date:  2007-05       Impact factor: 3.465
View more
  25 in total

Review 1.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

2.  Rational Design of a Novel AMPA Receptor Modulator through a Hybridization Approach.

Authors:  Nicola Caldwell; Jonathan E Harms; Kathryn M Partin; Craig Jamieson
Journal:  ACS Med Chem Lett       Date:  2015-02-11       Impact factor: 4.345

Review 3.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

4.  Pharmacological characterization of N-[(2S)-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1H-inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator.

Authors:  Simon E Ward; Paul Beswick; Novella Calcinaghi; Lee A Dawson; Jane Gartlon; Francesca Graziani; Declan N C Jones; Laurent Lacroix; M H Selina Mok; Beatrice Oliosi; Joanne Pardoe; Kathryn Starr; Marie L Woolley; Mark H Harries
Journal:  Br J Pharmacol       Date:  2017-01-31       Impact factor: 8.739

5.  Regulation of AMPA receptor subunit GluA1 surface expression by PAK3 phosphorylation.

Authors:  Natasha K Hussain; Gareth M Thomas; Junjie Luo; Richard L Huganir
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

6.  AnkG hemizygous mice present cognitive impairment and elevated anxiety/depressive-like traits associated with decreased expression of GABA receptors and postsynaptic density protein.

Authors:  Cui Liu; Ling Zhang; Jie Wu; Xiaolong Sui; Yanfeng Xu; Lan Huang; Yunlin Han; Hua Zhu; Yanhong Li; Xiuping Sun; Chuan Qin
Journal:  Exp Brain Res       Date:  2017-08-18       Impact factor: 1.972

7.  Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus.

Authors:  Xiaowei W Su; Xiao-Yuan Li; Mounira Banasr; Ja Wook Koo; Mohammed Shahid; Brian Henry; Ronald S Duman
Journal:  Psychopharmacology (Berl)       Date:  2009-07-15       Impact factor: 4.530

Review 8.  Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.

Authors:  Rodrigo Machado-Vieira; Giacomo Salvadore; Lobna A Ibrahim; Nancy Diaz-Granados; Carlos A Zarate
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 9.  New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.

Authors:  Zuleide M Ignácio; Gislaine Z Réus; Camila O Arent; Helena M Abelaira; Meagan R Pitcher; João Quevedo
Journal:  Br J Clin Pharmacol       Date:  2016-01-08       Impact factor: 4.335

10.  Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania.

Authors:  Steven T Szabo; Rodrigo Machado-Vieira; Peixiong Yuan; Yun Wang; Yanling Wei; Cynthia Falke; Chiara Cirelli; Giulio Tononi; Husseini K Manji; Jing Du
Journal:  Neuropharmacology       Date:  2008-08-22       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.